Figure S4 from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Anti-Tumor Activity Against Prostaglandin-Expressing Tumors
Year: 2023
Type: other
Abstract: TPST-1495 Displays T cell-independent anti-tumor efficacy in CT26.
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4384200451
